findmyKOL
Clinical trialNCT01116778CompletedPhase 3Interventional

the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis

SponsorGenMont Biotech IncorporationEnrollment236Lactobacillus Paracasei GMNL-32 (eN-Lac®)Perennial Allergic RhinitisProbiotics
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Taiwan
  • Chang Gung Children'S Hospital

    Taipei, Taipei, Taiwan

  • Mackay Memorial Hospital

    Taipei, Taipei, Taiwan

  • Taipei City Hospital Renai Branch

    Taipei, Taipei, Taiwan

  • Cardinal Tien Hospital

    Xindian, Taipei, Taiwan

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2010
Primary completion
31 Jan 2012
Completion
30 Jun 2012
Last update posted
2 Sept 2015
Registered enrollment
236
Registry id
NCT01116778

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.